Bath & Body Works Inc. (BBWI) PT Raised to $49 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Bath & Body Works Inc. (BBWI) PT Raised to $40 at Citi
November 26, 2024 6:36 AM ESTCiti analyst Paul Lejuez raised the price target on Bath & Body Works Inc. (NYSE: BBWI) to $40.00 (from $35.00) while maintaining a Neutral rating.
The analyst comments "3Q sales +3% and EPS $0.49 beat cons despite a slightly weaker GM vs cons. 3Q marked the... More
Bath & Body Works Inc. (BBWI) PT Raised to $34 at Barclays
November 26, 2024 6:19 AM ESTBarclays analyst Adrienne Yih raised the price target on Bath & Body Works Inc. (NYSE: BBWI) to $34.00 (from $28.00) while maintaining a Underweight rating.... More
Bath & Body Works Inc. (BBWI) PT Raised to $38 at Wells Fargo
November 26, 2024 6:14 AM ESTWells Fargo analyst Ike Boruchow raised the price target on Bath & Body Works Inc. (NYSE: BBWI) to $38.00 (from $32.00) while maintaining a Equal Weight rating.... More
Bath & Body Works Inc. (BBWI) PT Raised to $52 at Deutsche Bank
November 26, 2024 5:52 AM ESTDeutsche Bank analyst Gabriella Carbone raised the price target on Bath & Body Works Inc. (NYSE: BBWI) to $52.00 (from $51.00) while maintaining a Buy rating.
The analyst comments "BBWI's 3Q delivered its strongest sales growth in 10 quarters of +3.1% (vs. Street +1.2% and buy-side flat; 200 bps... More
Goldman Sachs Reiterates Buy Rating on Bath & Body Works Inc. (BBWI)
November 26, 2024 5:51 AM ESTGoldman Sachs analyst Kate McShane reiterated a Buy rating and $52.00 price target on Bath & Body Works Inc. (NYSE: BBWI)
The analyst comments "BBWI closed up 17% (vs. the S&P +0.3%) following its 3Q beat and raised FY24 guidance. We reiterate our Buy rating given BBWI is well-positioned to provide customers... More
Bath & Body Works Inc. (BBWI) PT Raised to $36 at Piper Sandler
November 25, 2024 4:10 PM ESTPiper Sandler analyst Korinne Wolfmeyer raised the price target on Bath & Body Works Inc. (NYSE: BBWI) to $36.00 (from $35.00) while maintaining a Neutral rating.
The analyst comments "BBWI delivered better than expected results both from the top line and continued cost savings to support... More
BofA Securities on Bath & Body Works Inc. (BBWI): 'Strong execution leading into holiday'
November 25, 2024 8:13 AM ESTBofA Securities analyst Lorraine Hutchinson reiterated a Buy rating and $45.00 price target on Bath & Body Works Inc. (NYSE: BBWI).
The analyst comments "BBWIs sales beat provides the first proof point that innovation in core, adjacencies and collaborations can offset pressure in candles. The 4Q... More
Bath & Body Works forecasts smaller drop in annual sales on strong holiday demand
November 25, 2024 7:47 AM EST(Reuters) -Bath & Body Works on Monday raised its forecast for full-year adjusted profit and projected a smaller drop in annual sales on strong demand for its candles and fragrances during the holiday season, sending the retailer's shares up about 22%.
The Ohio-based company introduced new products including its new winter range of fragrances such as Winter Candy Apple and Frosted Coconut Snowball to keep up with competition and help tackle softer demand in... More
Bath & Body Works, Inc. (BBWI) Tops Q3 EPS by 2c
November 25, 2024 7:00 AM ESTBath & Body Works, Inc. (NYSE: BBWI) reported Q3 EPS of $0.49, $0.02 better than the analyst estimate of $0.47. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.58 billion.
2024 Guidance
The company expects the 13-week fourth quarter 2024 net sales to range between a decline of 6.5% to a decline of 4.5%, compared to $2,912 million for... More

